Through registering your interest through any email registration form on this website, you are requesting Angel Association to communicate with you via email.
You will be added to the applicable mailing list and we will communicate with you as appropriate, via either personal or bulk email.
You will have the option of being removed from our mailing list at any time, by clicking 'unsubscribe' at the bottom of any bulk e-mail communication, or contacting us at any time through this website.
We take your privacy seriously and will not redistribute any of your contact details or personal information to any other third party.
Your contact details will be used for the sole purpose of responding to your requests, or keeping you informed via bulk e-mail.
Cure Kids Ventures Ltd is the separate investment entity of leading childhood health research charity Cure Kids, an organisation established over 30 years ago to address the lack of research into life-threatening childhood illnesses in New Zealand.
Since then, Cure Kids have invested over $19 million in medical research. This research has helped save hundreds of young lives and has improved the quality of life for thousands of children.
Today, we are more committed than ever to help find answers to the many cruel, life-threatening illnesses that devastate the lives of young children and their families. The research funded by Cure Kids has already led directly to several exciting commercial applications such as A2, Nexus 6, and Living Cell Technologies.
The goal of Cure Kids Ventures Limited is to maximise and leverage promising research into collaborative research, venture investment and ultimately commercialisation, which can then be reinvested back into childhood health.
PO Box 105-384, Auckland 1143
Contact: Maxine Simmons, CEO
M: 021 625 635